James M. Thorburn - 18 Feb 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Signature
/s/ William Solis, as Attorney-in-Fact for James M. Thorburn
Issuer symbol
TWST
Transactions as of
18 Feb 2022
Net transactions value
-$200,753
Form type
4
Filing time
23 Feb 2022, 17:03:25 UTC
Previous filing
26 Jan 2022
Next filing
07 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Tax liability $54,540 -1,025 -2.1% $53.21 47,925 18 Feb 2022 Direct F1
transaction TWST Common Stock Options Exercise $40,443 +1,517 +3.2% $26.66 49,442 22 Feb 2022 Direct
transaction TWST Common Stock Options Exercise $46,660 +2,000 +4% $23.33 51,442 22 Feb 2022 Direct
transaction TWST Common Stock Sale $128,057 -2,461 -4.8% $52.03 48,981 22 Feb 2022 Direct F2, F3
transaction TWST Common Stock Sale $70,914 -1,341 -2.7% $52.88 47,640 22 Feb 2022 Direct F2, F4
transaction TWST Common Stock Sale $34,345 -640 -1.3% $53.66 47,000 22 Feb 2022 Direct F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1,517 -3.5% $0.000000 41,898 22 Feb 2022 Common Stock 1,517 $26.66 Direct F6
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -2,000 -6.7% $0.000000 27,748 22 Feb 2022 Common Stock 2,000 $23.33 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F2 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $51.44 to $52.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $52.45 to $53.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 Represents the weighted average sales price per share. The shares sold at prices ranging from $53.50 to $54.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.